Jim Simons Vivos Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.31 - $0.55 $17,158 - $30,441	-55,349 Reduced 62.26%	33,551 $17,000
Q1 2023 May 12, 2023	BUY	$0.32 - $1.88 $23,328 - $137,052	72,900 Added 455.63%	88,900 $30,000
Q4 2022 Feb 13, 2023	BUY	$0.35 - $20.75 $1,085 - $64,325	3,100 Added 24.03%	16,000 $6,000
Q2 2022 Aug 12, 2022	BUY	$1.12 - $2.18 $2,240 - $4,360	2,000 Added 18.35%	12,900 $17,000
Q1 2022 May 13, 2022	BUY	$1.63 - $3.63 $17,767 - $39,567	10,900 New	10,900 $29,000
Q3 2021 Nov 12, 2021	SELL	$2.71 - $5.9 $52,032 - $113,280	-19,200 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$4.83 - $9.67 $92,736 - $185,664	19,200 New	19,200 $95,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $78.2M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.